Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 397 | Longs Won 219/394 55% | Profit Factor 1.18 |
| Profitability | Shorts Won 3/3 100% | Standard Deviation $1,387.49 |
| Average Win $633.78 | Best Trade (Jan 25) $12,238.88 | Sharpe Ratio -276.72 |
| Average Loss -$681.52 | Worst Trade (Apr 18) -$6,581.81 | Z-Score -5.63 (100%) |
| Commissions $0 | Avg. Trade Length 1m 3w 6d | Expectancy $54.35 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | 0.03% | 0.19% | 0.88% | 3.06% | 8.76% | 21.81% | 48.72% |
| Consecutive Losing Trades | 178 | 161 | 143 | 125 | 107 | 89 | 71 | 54 | 36 | 18 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
ACAD Acadia Pharmaceuticals Inc. | 4,028.4 | $113,802.17 | $121,576.97 | - | $7,774.8 | 6.83% | 0.0 |